Stimulation of plasminogen activator inhibitor-1 expression in immortalized human trophoblast cells cultured under low levels of oxygen

Experimental Cell Research

Volumn 245, Issue 1, 1998, Pages 155-162

  Fitzpatrick, Tania E ^a   Graham, Charles H ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Heme protein; Hypoxia; Invasion; Oxygen; Plasminogen activator inhibitor 1, PAI 1; Trophoblast

Indexed keywords

MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ARTICLE; CELL CULTURE; CELL HYPOXIA; CELL IMMORTALIZATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RNA ANALYSIS;

TIRON;

EID: 0031797364     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1998.4240     Document Type: Article

References (66)

1. Andreasen, P. A., Kjoller, L., Christensen, L., and Duffy, M. J. (1997). The urokinase-type plasminogen activator system in cancer metastasis: A review. Int. J. Cancer 72, 1-22.
2. Danø, K., Behrendt, N., Brunner, N., Ellis, V., Ploug, M., and Pyke, C. (1994). The urokinase receptor. Protein structure and role in plasminogen activation and cancer invasion. Fibrinolysis 8, 189-203.
3. Mignatti, P., and Rifkin, D. B. (1996). Biology and chemistry of proteinases in tumor invasion. Physiol. Rev. 73, 161-195.
4. Vassalli, J. D., Sappino, A. P., and Belin, D. (1991). The plasminogen activator/plasmin system. J. Clin. Invest. 88, 1067-1072.
5. Kwaan, H. C. (1992). The plasminogen-plasmin system in malignancy. Cancer Metastasis Rev. 11, 291-311.
6. Ellis, V., Behrendt, N., and Danø, K. (1991). Plasminogen activation by receptor-bound urokinase. A kinetic study with cell associated and isolated receptor. J. Biol. Chem. 266, 12752-12758.
7. Saksela, O., and Rifkin, D. B. (1988). Cell-associated plasminogen activation: regulation and physiological functions. Annu. Rev. Cell Biol. 4, 93-126.
8. Pannekoek, H., Veerman, H., Lambers, H., Diergaarse, P., Verweij, C. L., van Zonneveld, A. J., and Van Mourik, J. A. (1986). Endothelial plasminogen activator inhibitor (PAI): A new member of the Serpin gene family. EMBO J. 5, 2539-2544.
9. Astedt, B., Lacander, I., and Ny, T. (1987). The placental type plasminogen activator inhibitor PAI-2. Fibrinolysis 1, 203-208.
10. Wohlwend, A., Belin, D., and Vassalli, J. D. (1987). Plasminogen activator-specific inhibitors produced by human monocytes/ macrophages. J. Exp. Med. 165, 320-339.
11. Pollanen, J., Vaheri, A., Tapiovaara, H., Riley, E., Bertram, K., Woodrow, G., and Stephens, R. W. (1990). Prourokinase activation on the surface of human rhabdomyosarcoma cells: localization and inactivation of newly formed urokinase-type plasminogen activator by recombinant class 2 plasminogen activator inhibitor. Proc. Natl. Acad. Sci. USA 87, 2230-2234.
12. Foekens, J. A., Schmitt, M., van Putten, W. L. J., Peters, H. A., Kramer, M. D., Janicke, F., and Klijn, J. G. M. (1994). Plasminogen activator inhibitor-1 and prognosis in primary breast cancer. J. Clin. Oncol. 12, 1648-1658.
13. Nekarda, N., Schmitt, M., Ulm, K., Wenninger, A., Vogelsand, H., Becker, K., Roder, J. D., Fink, U., and Siewert, J. R. (1994). Prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in completely resected gastric cancer. Cancer Res. 54, 2900-2907.
14. Pedersen, H., Grondahl-Hansen, J., Francis, D., Osterlind, K., Hansen, H. H., Danø, K., and Brunner, N. (1994). Urokinase and plasminogen activator inhibitor type 1 in pulmonary adenocarcinoma. Cancer Res. 54, 120-123.
15. Pedersen, H., Brunner, N., Francis, D., Osterlind, K., Ronne, E., Hansen, H. H., Danø, K., and Grondahl-Hansen, J. (1994). Prognostic impact of urokinase, urokinase receptor, and type 1 plasminogen activator inhibitor in squamous and large cell lung cancer tissue. Cancer Res. 54, 4671-4675.
16. Kuhn, W., Pache, L., Schmalfeldt, B., Dettmar, P., Schmitt, M., Janicke, F., and Graeff, H. (1994). Urokinase (uPA) and PAI-1 predict survival in advanced ovarian cancer patients (FIGO III) after radical surgery and platinum-based chemotherapy. Gynecol. Oncol. 55, 401-409.
17. Liu, G., Shuman, M. A., and Cohen, R. L. (1995). Co-expression of urokinase, urokinase receptor and PAI-1 is necessary for optimum invasiveness of cultured lung cancer cells. Int. J. Cancer 60, 501-506.
18. Waltz, D. A., Natkin, L. R., Fujita, R. M., Wei, Y., and Chapman, H. A. (1997). Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin. J. Clin. Invest. 100, 58-67.
19. Deng, G., Curriden, S. A., Wang, S., Rosenberg, S., and Loskutoff, D. J. (1996). Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release? J. Cell Biol. 134, 1563-1571.
20. Höckel, M., Schlenger, K., Aral, B., Mitze, M., Schaffer, U., and Vaupel, P. (1996). Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res. 56, 4509-4515.
21. Brizel, D. M., Scully, S. P., Harrelson, J. M., Layfield, L. J., Bean, J. M., Prosnitz, L. R., and Dewhirst, M. W. (1996). Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res. 56, 941-943.
22. Brizel, D. M., Sibley, G. S., Prosnitz, L. R., Scher, R. L., and Dewhirst, M. W. (1997). Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int. J. Radiat. Oncol. Biol. Phys. 38, 285-289.
23. Young, S. D., Marshall, R. S., and Hill, R. P. (1988). Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells. Proc. Natl. Acad. Sci. USA 85, 9533-9537.
24. Cuvier, C., Jang, A., and Hill, R. P. (1997). Exposure to hypoxia, glucose starvation and acidosis: effect on invasive capacity of murine tumor cells and correlation with cathepsin (L + B) secretion. Clin. Exp. Metastasis 15, 19-25.
25. Rodesch, F., Simon, P., Donner, C., and Jauniaux, E. (1992). Oxygen measurements in endometrial and trophoblastic tissues during early pregnancy. Obstet. Gynecol. 80, 283-285.
26. Graham, C. H., Fitzpatrick, T. E., and McCrae, K. R. (1998). Hypoxia stimulates urokinase receptor expression through a heme protein-dependent pathway. Blood 9, 3300-3307.
27. Graham, C. H., Macdonald-Goodfellow, S., and Fitzgerald, C. F. (1998). Hypoxia stimulates expression of the urokinase receptor in human breast cancer cells. Proc. Am. Assoc. Cancer Res. 89, 2030. [abstract]
28. Bianchi, E., Cohen, R. L., Thor, A. T., Todd, R. F. I., Mizukami, I. F., Lawrence, D. A., Ljung, B. M., Shuman, M. A., and Smith, H. S. (1994). The urokinase receptor is expressed in invasive breast cancer but not in normal breast tissue. Cancer Res. 54, 861-866.
29. de Vries, T. J., Quax, P. H., Denijn, M., Verrijp, K. N., Verheijen, J. H., Verspaget, H. W., Weidle, U. H., Ruiter, D. J., and van Muijen, G. N. (1994). Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression. Am. J. Pathol. 144, 70-81.
30. Del Vecchio, S., Stoppelli, M. P., Carriero, M. V., Fonti, R., Massa, O., Li, P. Y., Botti, G., Cerra, M., D'Aiuto, G., Esposito, G., and Salvatore, M. (1993). Human urokinase receptor concentrations in malignant and benign breast tumors by in vitro quantitative autoradiography: comparison with urokinase levels. Cancer Res. 53, 3198-3206.
31. Schmitt, M., Harbeck, N., Thomssen, C., Wilhelm, O., Magdolen, V., Reuning, U., Ulm, K., Hofler, H., Janicke, F., and Graeff, H. (1997). Clinical impact of the plasminogen activation system in tumor invasion and metastasis: prognostic relevance and target for therapy. Thromb. Haemostasis 78, 285-296.
32. Sier, C. F., Quax, P. H., Vloedgraven, H. J., Verheijen, J. H., Griffioen, G., Ganesh, S., Lamers, C. B., and Verspaget, H. W. (1993). Increased urokinase receptor levels in human gastrointestinal neoplasia and related liver metastases. Invasion Metastasis 13, 277-288.
33. Wagner, S. N., Atkinson, M. J., Thanner, S., Wagner, C., Schmitt, M., Wilhelm, O., Rotter, M., and Hofler, H. (1995). Modulation of urokinase and urokinase receptor gene expression in human renal cell carcinoma. Am. J. Pathol. 147, 183-192.
34. Dasch, J. R., Pace, D. R., Waegell, W., Inenaga, D., and Ellingsworth, L. (1989). Monoclonal antibodies recognizing transforming growth factor-beta: Bioactivity neutralization and transforming growth factor beta 2 affinity purification. J. Immunol. 142, 1536-1541.
35. Graham, C. H., Hawley, T. S., Hawley, R. G., MacDougall, J. R., Kerbel, R. S., Khoo, N., and Lala, P. K. (1993). Establishment and characterization of first trimester human trophoblast cells with extended lifespan. Exp. Cell Res. 206, 204-211.
36. Irving, J. A., Lysiak, J. J., Graham, C. H., Hearn, S., Han, V. K. M., and Lala, P. K. (1995). Characteristics of trophoblast cells migrating from first trimester chorionic villus explants and propagated in culture. Placenta 16, 413-433.
37. Irving, J. A., and Lala, P. K. (1995). Functional role of cell surface integrins on human trophoblast cell migration: Regulation by TGF-β, IGF-II, and IGFBP-1. Exp. Cell Res. 217, 419-427.
38. Sandberg, T., Eriksson, P., Gustavsson, B., and Casslen, B. (1997). Differential regulation of the plasminogen activator inhibitor-1 (PAI-1) gene expression by growth factors and progesterone in human endometrial stromal cells. Mol. Hum. Reprod. 3, 781-787.
39. Graham, C. H. (1996). Effect of transforming growth factor-β on the plasminogen activator system in cultured first trimester human cytotrophoblasts. Placenta 18, 137-143.
40. Hamilton, J. A., Wojta, J., Gallichio, M., McGrath, K., and Filonzi, E. L. (1993). Contrasting effects of transforming growth factor-beta and IL-1 on the regulation of plasminogen activator inhibitors in human synovial fibroblasts. J. Immunol. 151, 5154-5161.
41. Idell, S., Kumar, A., Zwieb, C., Holiday, D., Koening, K. B., and Johnson, A. R. (1994). Effects of TGF-beta and TNA-alpha on procoagulant and fibrinolytic pathways of human tracheal epithelial cells. Am. J. Physiol. 267, L693-703.
42. Wilson, H. M., Reid, F. J., Brown, P. A., Power, D. A., Haites, N. E., and Booth, N. A. (1993). Effect of transforming growth factor-beta 1 on plasminogen activators and plasminogen activator inhibitor-1 in renal glomerular cells. Exp. Nephrol. 1, 343-350.
43. Falanga, V., Qian, S. W., Danielpour, D., Katz, M. H., Roberts, A. B., and Sporn, M. B. (1991). Hypoxia upregulates the synthesis of TGF-beta 1 by human dermal fibroblasts. J. Invest. Dermatol. 97, 634-637.
44. Khaliq, A., Patel, B., Jarvis-Evans, J., Moriarty, P., McLeod, D., and Boulton, M. (1995). Oxygen modulates production of bFGF and TGF-beta by retinal cells in vitro. Exp. Eye Res. 60, 415-423.
45. Orphanides, C., Fine, L. G., and Norman, J. T. (1997). Hypoxia stimulates proximal tubular cell matrix production via a TGF-beta1-independent mechanism. Kidney Int. 52, 637-647.
46. Breen, E. C., Johnson, E. C., Wagner, H., Tseng, H. M., Sung, L. A., and Wagner, P. D. (1996). Angiogenic growth factor mRNA responses in muscle to a single bout of exercise. J. Appl. Physiol. 81, 355-361.
47. Goldberg, M. A., Dunning, S. P., and Bunn, H. F. (1988). Regulation of the erythropoietin gene: evidence that the oxygen sensor is a heme protein. Science 242, 1412-1415.
48. Bosma, P. J., Kooistra, T., Siemieniak, D. R., and Slightom, J. L. (1991). Further characterization of the 5′-flanking DNA of the gene encoding human plasminogen activator inhibitor-1. Gene 100, 261-266.
49. Bosma, P. J., van den Berg, E. A., Kooistra, T., Siemieniak, D. R., and Slightom, J. L. (1988). Human plasminogen activator inhibitor-1 gene: Promoter and structural gene nucleotide sequences. J. Biol. Chem. 263, 9129-9141.
50. Forsythe, J. A., Jiang, B., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., and Semenza, G. L. (1996). Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol. 16, 4604-4613.
51. Semenza, G. L., Roth, P. H., Fang, H.-M., and Wang, G. L. (1994). Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J. Biol. Chem. 269, 23757-23763.
52. Lee, P. J., Jiang, B.-H., Chin, B. Y., Iyer, N. V., Alam, J., Semenza, G. L., and Choi, A. M. K. (1997). Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia. J. Biol. Chem. 272, 5375-5381.
53. Gleadle, J. M., and Ratcliffe, P. J. (1997). Induction of hypoxia-inducible factor-1, erythropoietin, vascular endothelial growth factor, and glucose transporter-1 by hypoxia: evidence against a regulatory role for Src kinase. Blood 89, 503-509.
54. Alsat, E., Wyplosz, P., Malassine, A., Guibourdenche, J., Porquet, D., Nessmann, C., and Evain-Brion, D. (1996). Hypoxia impairs cell fusion and differentiation process in human cytotrophoblast in vitro. J. Cell. Physiol. 168, 346-353.
55. Esterman, A., Greco, M. A., Mitani, Y., Finlay, T. H., Ismail-Beigi, F., and Dancis, J. (1997). The effect of hypoxia on human trophoblast in culture: morphology, glucose transport and metabolism. Placenta 18, 129-136.
56. Wojta, J., Jones, R. L., Binder, B. R., and Hoover, R. L. (1988). Reduction in pO2 decreases the fibrinolytic potential of cultured bovine endothelial cells derived from pulmonary arteries and lung microvasculature. Blood 71, 1703-1706.
57. Kingdom, J. C., and Kaufmann, P. (1997). Oxygen and placental villous development: origins of fetal hypoxia. Placenta 18, 613-621.
58. Estelles, A., Gilabert, J., Keeton, M., Eguchi, Y., Aznar, S., Espana, F., Loskutoff, D. J., and Schleef, R. R. (1994). Altered expression of plasminogen activator inhibitor type 1 in placentas from pregnant women with preeclampsia and/or intrauterine fetal growth retardation. Blood 84, 143-150.
59. Woodhouse, E. C., Chuaqui, R. F., and Liotta, L. A. (1997). General mechanisms of metastasis. Cancer 80, 1529-1537.
60. Kanse, S. M., Kost, C., Wilhelm, O. G., Andreasen, P. A., and Preissner, K. T. (1996). The urokinase receptor is a major vitronectin-binding protein on endothelial cells. Exp. Cell Res. 224, 344-353.
61. Waltz, D. A., and Chapman, H. A. (1994). Reversible cellular adhesion to vitronectin linked to urokinase receptor occupancy. J. Biol. Chem. 269, 14746-14750.
62. Busso, N., Masur, S. K., Lazega, D., Waxman, S., and Ossowski, L. (1994). Induction of cell migration by pro-urokinase binding to its receptor: possible mechanism for signal transduction in human epithelial cells. J. Cell Biol. 126, 259-270.
63. Wei, Y., Lukashev, M., Simon, D. I., Bodary, S. C., Rosenberg, S., Doyle, M. V., and Chapman, H. A. (1996). Regulation of integrin function by urokinase receptor. Science 373, 1551-1555.
64. 5-directed cell migration. J. Biol. Chem. 271, 29393-29399.
65. Kjoller, L., Kanse, S. M., Kirkegaard, T., Rodenburg, K. W., Ronne, E., Goodman, S. L., Preissner, K. T., Ossowski, L., and Andreasen, P. A. (1997). Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation. Exp. Cell Res. 232, 420-429.
66. 3 binding to vitronectin. Nature 383, 441-443.